Our Mission
Pioneering Medical Breakthroughs
At Kong's Pharmaceutical Company, we are committed to developing cutting-edge endocrine and oncology medicines derived from small molecule compounds. Our research focuses on creating innovative solutions to aid the recovery process, providing hope and treatment to patients around the world.
Endocrine Drug Development:
With the global population aging—those over 60 soon exceeding 20%—there is an increasing demand for endocrine support to enhance quality of life, particularly in sexual health.
​
We are developing innovative solutions to support the aging population by restoring and maintaining optimal endocrine system function in both men and women.
​​
Vision and Mission in Oncology Drug Development:
Oncology drugs are critical in the fight against cancer, providing patients with targeted therapies that address specific cancer types and mutations. We are committed to developing groundbreaking oncology drugs that offer new hope to cancer patients.
​
Our mission is to create groundbreaking oncology therapies that target cancer cell growth by suppression of its nutrition uptake, offering effective and accessible treatments for cancer patients worldwide. Rather than focusing on destroying cancer cells, our strategy is to slow tumor progression, transforming cancer from a life-threatening condition to a manageable chronic disease.
Project Updates:
CR-067 for the treatment of Erectile Dysfunction is expected to enter Phase 2 clinical trials in 2025, marking an important step toward ensuring its safety and efficacy. We are eager to advance our promising treatment approach and remain optimistic that the trial will have positive results.
The K-119 oncology drug is a small-molecule oral therapy designed to target bladder cancer. Having successfully completed preclinical testing, we plan to submit an Investigational New Drug (IND) application in the second half of 2025. Preclinical studies have demonstrated its strong efficacy and excellent safety profile, reinforcing its potential as a breakthrough treatment.
Industry Sponsors and Partnerships
We are proud to collaborate with a network of dedicated sponsors and partners who share our commitment to innovation and excellence. Their support enables us to advance our mission, drive groundbreaking research, and develop impactful solutions.